Loading...
Vor Biopharma Inc.
VOR•NASDAQ
Healthcare
Biotechnology
$2.10
$0.03(1.45%)
Vor Biopharma Inc. (VOR) Financial Performance & Income Statement Overview
Review Vor Biopharma Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
3.85%
↑ 3.85%
Net Income Growth
0.81%
↑ 0.81%
Operating Cash Flow Growth
0.63%
↑ 0.63%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-142.13%
↓ 142.13%
ROIC
-131.93%
↓ 131.93%
Vor Biopharma Inc. (VOR) Income Statement & Financial Overview
Review Vor Biopharma Inc.'s (VOR) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $50.05M | $81.95M | $52.80M | $76.08M |
| Short Term Investments | $9.99M | $9.98M | $10.01M | $9.86M |
| Cash & Short Term Investments | $60.03M | $91.93M | $62.81M | $85.94M |
| Net Receivables | $0.00 | $0.00 | $0.00 | $0.00 |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Assets | $4.81M | $4.58M | $4.49M | $4.32M |
| Total Current Assets | $64.85M | $96.51M | $67.30M | $90.26M |
| Property Plant & Equipment (Net) | $39.68M | $41.59M | $43.77M | $45.86M |
| Goodwill | $0.00 | $0.00 | $0.00 | $0.00 |
| Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill & Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Long Term Investments | $0.00 | $0.00 | $0.00 | $2.41M |
| Tax Assets | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Assets | $4.78M | $14.92M | $4.92M | $3.06M |
| Total Non-Current Assets | $44.47M | $56.51M | $48.70M | $51.33M |
| Total Assets | $109.31M | $142.89M | $115.99M | $141.59M |
| Account Payables | $3.73M | $1.50M | $1.32M | $2.007M |
| Short Term Debt | $4.27M | $4.21M | $4.16M | $8.23M |
| Tax Payables | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Current Liabilities | $8.73M | $12.89M | $8.87M | $3.57M |
| Total Current Liabilities | $16.73M | $18.61M | $14.35M | $13.80M |
| Long Term Debt | $26.52M | $27.61M | $28.69M | $29.71M |
| Deferred Revenue Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Deferred Tax Liabilities Non-Current | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Non-Current Liabilities | $0.00 | $0.00 | $0.00 | $0.00 |
| Total Non-Current Liabilities | $26.52M | $27.61M | $28.69M | $29.71M |
| Capital Lease Obligations | $30.78M | $31.83M | $32.85M | $29.71M |
| Total Liabilities | $43.24M | $46.23M | $43.04M | $43.51M |
| Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock | $13000.00 | $13000.00 | $7000.00 | $7000.00 |
| Retained Earnings | -$489.48M | -$456.99M | -$426.28M | -$398.72M |
| Accumulated Other Comprehensive Income/Loss | $23000.00 | $22000.00 | $68000.00 | -$70000.00 |
| Total Stockholders Equity | $66.07M | $96.66M | $72.95M | $98.08M |
| Total Equity | $66.07M | $96.66M | $72.95M | $98.08M |
| Total Liabilities & Stockholders Equity | $109.31M | $142.89M | $115.99M | $141.59M |
| Total Investments | $9.99M | $9.98M | $10.01M | $12.28M |
| Total Debt | $30.78M | $31.83M | $32.85M | $33.82M |
| Net Debt | -$19.27M | -$50.12M | -$19.94M | -$42.26M |
Vor Biopharma Inc. (VOR) Balance Sheet Analysis
Vor Biopharma Inc. (VOR) manages its money wisely, with plenty of 0.63% and 0.81% to cover its bills. The company’s long-term debts are manageable, balanced by steady 0.00%. Shareholders’ stake in the business has shrunk. Overall, the numbers show a stable position, giving it room to invest, expand, or adapt. For investors, this paints a steady picture for the future.Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan